88 results on '"Roxanis, Ioannis"'
Search Results
52. Capturing Global Spatial Context for Accurate Cell Classification in Skin Cancer Histology
53. Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
54. A case of breast carcinosarcoma with associated myoepitheliosis-like change and morule-like squamous metaplasia. Discussion of possible pathogenetic links
55. Aberrant Encounter of Acetylcholine Receptor-Expressing Cells with the Lymphoid Infiltrates in the Thymus of Myasthenia Gravis Patients
56. Thymoma and Autoimmune Neurological Disorders : A Search for Missing Links in Pathogenesis
57. Cellular cohesion as a prognostic factor in malignant melanoma: a retrospective study with up to 12 years follow-up
58. Assessment of the Molecular Heterogeneity of E-Cadherin Expression in Invasive Lobular Breast Cancer
59. ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression
60. Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell Carcinoma
61. 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
62. Occurrence and significance of epithelial-mesenchymal transition in breast cancer
63. SF3B1hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response
64. A FIJI macro for quantifying pattern in extracellular matrix
65. SuperHistopath: A Deep Learning Pipeline for Mapping Tumor Heterogeneity on Low-Resolution Whole-Slide Digital Histopathology Images
66. Superpixel-based conditional random fields (SuperCRF) : incorporating global and local context for enhanced deep learning in melanoma histopathology
67. A FIJI Macro for quantifying pattern in extracellular matrix
68. A Pathogenetic Role for the Thymoma in Myasthenia Gravis: Autosensitization of IL-4-producing T Cell Clones Recognizing Extracellular Acetylcholine Receptor Epitopes Presented by Minority Class II Isotypes
69. Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis
70. True epithelial hyperplasia in the thymus of early-onset myasthenia gravis patients: implications for immunopathogenesis
71. Functionally defined CD164 epitopes are expressed on CD34+ cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues
72. Metformin increases 18F-FDG flux and inhibits fatty acid oxidation at clinical doses in breast cancer: Results of a phase 0 clinical trial
73. Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer
74. Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth
75. Abstract 2903: Differential regulation of LC3 A and B, GABARAPL 1 and 2 autophagy genes by micro-environmental stress and role in breast cancer survival
76. Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer
77. Quality of life among Greek smokers and nonsmokers. A study in local community workers in Athens suburbia
78. ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer
79. Recurrent PTPRB and PLCG1 mutations in angiosarcoma
80. Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer
81. Abstract 531: HER4 cleavage and nuclear localization mediate Trastuzumab resistance in HER2-positive breast cancer.
82. Potential of PET to Predict the Response to Trastuzumab Treatment in an ErbB2-Positive Human Xenograft Tumor Model
83. Psychometric properties of the Metacognitions Questionnaire-30 (MCQ-30) in a Greek sample
84. Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
85. Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
86. Investigating the role of ADAM10 and ADAM17 in cetuximab resistance in head and neck squamous cell carcinoma
87. PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer.
88. Superpixel-Based Conditional Random Fields (SuperCRF): Incorporating Global and Local Context for Enhanced Deep Learning in Melanoma Histopathology.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.